Katelaris C H
Department of Clinical Immunology and Allergy, Westmead Hospital, New South Wales.
Aust Fam Physician. 1998 Aug;27(8):687-92.
Allergen-specific immunotherapy has been used to treat allergic patients for many decades. Numerous clinical trials have demonstrated its efficacy in patients with seasonal allergic rhinitis, perennial allergic rhinitis, stinging insect allergy and allergic asthma.
This article discusses antigen specific immunotherapy and outlines the conditions that respond well to it.
Immunotherapy has the potential to cause immediate systemic reactions which rarely may result in fatal anaphylaxis. Therefore, only practitioners with appropriate training and expertise should make the decision to prescribe immunotherapy based on careful patient selection and extract prescription. Patients receiving this therapy require supervision in a setting with the necessary resuscitation equipment by a practitioner with the skills to recognise and treat adverse events.
变应原特异性免疫疗法已用于治疗过敏患者数十年。众多临床试验已证明其对季节性变应性鼻炎、常年性变应性鼻炎、昆虫叮咬过敏和变应性哮喘患者有效。
本文讨论抗原特异性免疫疗法，并概述对其反应良好的病症。
免疫疗法有可能引发即刻全身性反应，极少情况下可能导致致命性过敏反应。因此，只有经过适当培训且具备专业知识的从业者，才应在仔细选择患者并开具提取物处方的基础上，决定是否开具免疫疗法。接受该疗法的患者需要在配备必要复苏设备的环境中，由具备识别和治疗不良事件技能的从业者进行监督。
